Drug - Azilect (rasagline) 0.5 mg, 1mg
November 2007
Therapeutic area - Parkinson’s disease
Azilect is an MOA inhibitor with all of the associated warnings and drug and food interactions and is indicated only for idiopathic Parkinson’s disease.
Patient is being treated for Parkinson’s disease and is intolerant to selegiline.
Questions?
MHCP Provider Call Center 651-431-2700 or 800-366-5411
